A surgical team at Peking University Shougang Hospital has successfully performed a complex liver resection for hepatocellular carcinoma using the SHURUI® single-port surgical system, marking the first case of its kind in China. The patient, a 63-year-old male with cirrhosis and a centrally located liver tumor, was treated through a single 3–4 cm umbilical incision.
Led by Dr. Jianjun Leng, the team employed preoperative interventional therapy and 3D modeling to shrink the tumor and precisely map vascular anatomy. During surgery, SHURUI® single-port surgical robot delivered exceptional dexterity and visualization, enabling precise dissection around critical blood vessels with minimal blood loss and trauma.
This milestone case showcases the potential of Chinese surgical robotics in hepatobiliary oncology. With its ultra-minimally invasive design, the SHURUI® system expands the boundaries of complex liver surgery—ushering in a new era of precision and patient-centered care in China.
The SHURUI Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has obtained the CE marking for urologic laparoscopic surgical procedures, gynecologic laparoscopic surgical procedures, general laparoscopic surgical procedures, and thoracoscopic surgical procedures. It is intended for use by trained surgeons in an operating room environment in accordance with the representative, specific procedures set forth in the User Manual.
Safety and Performance Information
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other trademarks and may not be used without permission.